None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Japanese males and females aged of 20-64 years. 2)Subjects who defecate 2-5 times from the screening test per week. 3)Subjects who can drink coffee every day 4)Subjects who can visit the study site on the scheduled date 5)Subjects who recognize the object and contents of the study and submit the written informed consent.
Exclusion criteria
Exclusion criteria: 1)Subjects who regularly use laxatives or antibiotics 2)Subjects with a history or current history of serious diseases such as heart, liver, kidney, cancer, or tuberculosis (including cases of complications of other diseases) 3)Subjects who are currently receiving medication for illness or injury at the time of screening (excluding those prescribed medication for transient symptoms such as colds or hay fever) or who are scheduled to undergo surgery during the study period 4)Subjects who regularly use medicines, quasi-drugs, health foods and supplements (such as capsules) affecting the study. 5)Subjects who are shift workers or graveyard shift workers. 6)Subjects with extremely irregular daily habits and eating habits. 7)Subjects who will experience major changes in their living environment (such as moving, relocation, etc.) during the study period 8)Subjects who usually intake heavy amount of alcohol (40g alcohol/day>=) or smokers. 9)Subjects who have ever felt unwell due to blood sampling. 10)Subjects who may have allergic symptoms to the test food 11)Subjects who donated 200 mL or more of blood within 1 month from the screening test or who are scheduled to do so during the study period 12)Subjects already participating in other clinical trials or who plan to participate in other clinical trials between the time of obtaining consent for this study and the final examination 13)Pregnant, breastfeeding, or likely to become pregnant during the study period 14)Subjects who are ineligible due to physician's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| POMS2 Japanese version | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue VAS,State-Trait Anxiety Inventory-Form JYZ (STAI),Oguri-Shirakawa-Azumi Sleep Inventory MA version | — |
Countries
Japan
Contacts
Trans Genic Inc. Clinical Research Department